){kind=logo}
09:30
10:30
-
There's a common belief about what drives value in medical aesthetics, often disconnected from what investors underwrite. As investors grow more disciplined on earnings quality, growth, and diligence, platforms and founder-owned businesses need to understand what buyers can underwrite in today's environment. Skytale's teams guide attendees through the operational levers driving enterprise value, using case studies on how investors strengthen earnings, scalability, and value.
11:30
11:40
-
Ask most operators which location is hiding behind the portfolio average, or which provider is quietly driving retention, and the answer is a shrug or a spreadsheet. That's not a discipline problem - it's a visibility problem. See how rebuilding your reporting experience surfaces the actions needed to get ahead of the competition, elevating EBITDA by 8'20% in year one, with no new locations and no extra marketing spend.
12:40
13:40
-
Scale rapidly exposes operational gaps. As regulatory scrutiny intensifies, uncover how to build compliant systems and harmonize operations across state lines ' protecting your patients, your reputation, and your bottom line, without allowing complexity to limit growth.
14:40
14:50
-
Growing from one aesthetics practice to hundreds of locations takes more than a bigger ad budget. In this session, we discuss how to scale digital marketing without diluting the brand. Learn how to balance national consistency with local search visibility, build repeatable patient acquisition systems, and measure what drives profitable growth in 2027, all while also managing the revolution of AI changing search behaviors constantly.
15:50
16:00
-
AI amplifies whatever it runs on ' strength or fragility. As AI agents take on booking, follow-up, documentation and insight, aesthetics operators face real upside: less staff strain, clearer profit drivers, stronger retention ' and real risk: bad data turned into confident mistakes at scale. See where the biggest opportunities sit today, what patient safety and data quality demand first, and how to build for resilience and freedom.
08:00
09:10
-
The rules of growth are changing. As competition intensifies and consumers become more discerning, enterprise leaders must rethink where value is created. Discover the commercial, competitive and consumer forces shaping the industry's next chapter.
-
Staying relevant means understanding how consumer expectations will define tomorrow's market. Explore the generational shifts and wellness trends influencing treatment demand, premiumization, and purchasing decisions to build a more resilient, future-ready enterprise.
09:30
-
Growth creates opportunity, and the operators who capture it most effectively are those who master the fundamentals. Enterprise leaders share how they're strengthening purchasing, inventory automation, AI forecasting, and operational discipline to improve visibility, reduce hidden costs, and build more efficient businesses that scale sustainably.
-
As patient expectations continue to rise, lasting loyalty is built through every interaction, not just every treatment. Master the art of designing memorable patient journeys that strengthen trust, increase retention, inspire word-of-mouth referrals and maximise lifetime value.
10:00
-
Leading medspas aren't casually offering patient financing, they're embedding it into workflows that drive patient acquisition and revenue growth. Hear how enterprise operators leverage promotional financing, CRM integrations, preapproval campaigns, and dedicated sales outreach to generate leads, increase conversions, and unlock new revenue opportunities.
-
Competition for today's consumer is fierce, but does your perception of the market match reality? Challenge outdated assumptions around who the aesthetics consumer is, where future growth will come from, and how expanding your addressable market can redefine enterprise opportunity, close the valuation gap, and reveal consumer appetites for aesthetics.
11:30
-
Not every KPI deserves equal attention. At scale, knowing which metrics to rely and act on becomes a competitive advantage. Leverage the right indicators to improve profitability, anticipate risk, and forecast opportunity to prioritise success across every location.
-
Patients rarely present with just one concern, and a curated menu should reflect those needs without overwhelming them with choice. Uncover how leading operators are designing signature treatment menus, including combination offerings, that differentiate them in a sea of aesthetic storefronts - meeting the demands of today's patients, and generating financial returns.
12:00
-
Acquisition creates scale on paper, but turning a multi-location rollup into a single business requires knowing what to standardise, and what not to. Dive into the post-acquisition decisions across service delivery, staffing, pricing, systems and reporting ' what can go wrong, and where alignment creates growth.
-
From a single treatment to a strategic entry point, microneedling has merged clinical outcomes with commercial growth. Master integration across every location ' building the protocol and consistency that protect margin per treatment, securing a reliable, scalable revenue line for your portfolio.
12:30
14:00
-
The technology that fuels growth can quickly become the biggest barrier to it. Build a streamlined operating foundation that scales with you, integrating your data, systems, and teams to advance AI adoption and improve end-to-end visibility. Decide what to retain, replace or consolidate to prioritize spend, protect your margins, and support enterprise growth.
-
Today's aesthetics patient no longer fits a standard treatment pathway. With accelerating GLP-1 use and evolving patient needs, rethink how treatments are introduced, combined, and priced to build proven personalized protocols - turning new demographic demand into repeatable revenue without allowing complexity to dilute your margins.
14:30
-
Premium scale platforms are commanding 8'10x+ EBITDA - but getting there isn't just about size. Top insiders break down what's really driving deal structures in 2027, how MSO models are evolving, and how to solve for maximum enterprise value, whether you're building, buying, or exiting.
-
As exosomes, peptides and next-generation therapies gain momentum, enterprise medspas must decide what belongs on the menu ' and what is ready to scale. Weigh consumer demand, evolving evidence, and the rewards of building repeatable protocols across locations, to strengthen patient trust, protect clinical credibility, and support sustainable growth.
15:45
-
As competition intensifies in established markets, should expansion rely on precision or pace? Position your business to identify untapped opportunities ' balancing portability, performance in local markets and consistency at scale, to strengthen your portfolio's identity and long-term returns.
-
When rosters and treatment menus expand, provider variability intensifies ' hurting both conversion and productivity. Uncover how leading operators are standardising evidence-led recommendations, realistic goal setting, and consistent care delivery to empower patients with the confidence that earns repeat business and long-term adherence.
16:15
-
When talent is the real ceiling on your growth, find out how leading operators combine hiring, development and automation to build teams that scale. Rethink roles and management responsibilities as AI takes on everyday administration, and explore how training, progression and accountability can improve productivity, retain your best people and build a culture that scales.
-
The brands winning today's consumer are the ones delivering consistency long before the first appointment. Unpack how enterprise medspas align positioning, reputation and AI-powered engagement across every location - without losing local relevance - to convert attention into booked appointments and commercial growth.
16:45
09:00
09:10
-
Across longevity, recovery and wellness, evolving consumer preferences are challenging enterprise leaders to build strategically without adding noise. Capitalize on demand for regenerative therapies, recovery protocols and hormone-based care, balancing appetites for innovation with operational complexity, to strengthen engagement and deliver proven results.
09:40
-
For leading operators embracing agility and automation, AI is unlocking new strategies for scale. Hear the hard-won lessons on where proactive integration creates the greatest value, and how connected data, shared context and intelligent systems are freeing enterprise leaders to unlock efficiencies, boost consistency and drive long-term performance.
10:10
11:10
-
Treatment value is lost when the procedure and post-care are treated as separate decisions. Rethink how treatments are designed, bundled, and priced to create repeatable patient pathways - improving adherence and outcomes while strengthening the economics of every procedure.
11:40
-
Not all membership programs are built the same - and the performance isn't in the perks or the price point. Unpack what the strongest programs have in common, how they're structured to build genuine belonging, influence patient and provider behavior, and what that means for retention, spend, and revenue over time.
12:10
13:40